Document Type


Publication Date



Abstract: Electroconvulsive therapy (ECT) is a rapid and effective treatment for multiple types of mental illness including major depressive disorder, bipolar depression, and catatonia. ECT can result in multiple cognitive side effects including post-ECT delirium as well as anterograde and retrograde amnesia. Administering formal cognitive screening at baseline, during, and after completion of ECT could be an effective means of monitoring for cognitive side effects from ECT. Conducting cognitive screening in an outpatient ECT service poses multiple challenges including time, limited staff, and availability of trained staff to administer cognitive screening. After reviewing multiple cognitive screens, the Self-Administered Gerocognitive Examination (SAGE) is a self-administered cognitive screen that can be completed at home and could be a good fit for screening for cognitive side effects in an outpatient ECT service. Future directions of the project include creating a protocol for cognitive screening, training staff to score the SAGE, and testing the cognitive screening protocol.


Presented at the University of New Mexico GME/CPL 2021 Annual Quality Improvement and Patient Safety Symposium.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.